Guardant Health
GH
#1169
Rank
S$24.96 B
Marketcap
S$184.54
Share price
-0.52%
Change (1 day)
47.25%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): S-$4.50

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is S-$4.49. In 2025 the company made an earnings per share (EPS) of S-$4.26 an increase over its 2024 EPS that were of S-$4.59.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$4.505.44%
2025S-$4.26-7.02%
2024S-$4.59-16.82%
2023S-$5.51-33.13%
2022S-$8.2460%
2021S-$5.1555.04%
2020S-$3.32207.14%
2019S-$1.08-19.81%
2018S-$1.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
S-$0.33-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
S-$3.16-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA